104 related articles for article (PubMed ID: 29769419)
1. Heart rate reduction with ivabradine in the early phase of atherosclerosis is protective in the endothelium of ApoE-deficient mice.
Aquila G; Morelli MB; Vieceli Dalla Sega F; Fortini F; Nigro P; Caliceti C; Ferracin M; Negrini M; Pannuti A; Bonora M; Pinton P; Ferrari R; Rizzo P
J Physiol Pharmacol; 2018 Feb; 69(1):35-52. PubMed ID: 29769419
[TBL] [Abstract][Full Text] [Related]
2. Heart rate reduction with ivabradine improves erectile dysfunction in parallel to decrease in atherosclerotic plaque load in ApoE-knockout mice.
Baumhäkel M; Custodis F; Schlimmer N; Laufs U; Böhm M
Atherosclerosis; 2010 Sep; 212(1):55-62. PubMed ID: 20347444
[TBL] [Abstract][Full Text] [Related]
3. Heart rate reduction by ivabradine reduces oxidative stress, improves endothelial function, and prevents atherosclerosis in apolipoprotein E-deficient mice.
Custodis F; Baumhäkel M; Schlimmer N; List F; Gensch C; Böhm M; Laufs U
Circulation; 2008 May; 117(18):2377-87. PubMed ID: 18443241
[TBL] [Abstract][Full Text] [Related]
4. Heart rate reduction by ivabradine improves aortic compliance in apolipoprotein E-deficient mice.
Custodis F; Fries P; Müller A; Stamm C; Grube M; Kroemer HK; Böhm M; Laufs U
J Vasc Res; 2012; 49(5):432-40. PubMed ID: 22759927
[TBL] [Abstract][Full Text] [Related]
5. Differential effects of heart rate reduction with ivabradine in two models of endothelial dysfunction and oxidative stress.
Kröller-Schön S; Schulz E; Wenzel P; Kleschyov AL; Hortmann M; Torzewski M; Oelze M; Renné T; Daiber A; Münzel T
Basic Res Cardiol; 2011 Nov; 106(6):1147-58. PubMed ID: 21964558
[TBL] [Abstract][Full Text] [Related]
6. Nebivolol, but not metoprolol, improves endothelial function of the corpus cavernosum in apolipoprotein e-knockout mice.
Baumhäkel M; Schlimmer N; Büyükafsar K; Arikan O; Böhm M
J Pharmacol Exp Ther; 2008 Jun; 325(3):818-23. PubMed ID: 18364472
[TBL] [Abstract][Full Text] [Related]
7. Heart rate reduction with ivabradine promotes shear stress-dependent anti-inflammatory mechanisms in arteries.
Luong L; Duckles H; Schenkel T; Mahmoud M; Tremoleda JL; Wylezinska-Arridge M; Ali M; Bowden NP; Villa-Uriol MC; van der Heiden K; Xing R; Gijsen FJ; Wentzel J; Lawrie A; Feng S; Arnold N; Gsell W; Lungu A; Hose R; Spencer T; Halliday I; Ridger V; Evans PC
Thromb Haemost; 2016 Jul; 116(1):181-90. PubMed ID: 27075869
[TBL] [Abstract][Full Text] [Related]
8. Heart-rate reduction by If-channel inhibition with ivabradine restores collateral artery growth in hypercholesterolemic atherosclerosis.
Schirmer SH; Degen A; Baumhäkel M; Custodis F; Schuh L; Kohlhaas M; Friedrich E; Bahlmann F; Kappl R; Maack C; Böhm M; Laufs U
Eur Heart J; 2012 May; 33(10):1223-31. PubMed ID: 21821843
[TBL] [Abstract][Full Text] [Related]
9. Effect of 7-difluoromethyl-5, 4'-dimethoxygenistein on aorta atherosclerosis in hyperlipidemia ApoE(-/-) mice induced by a cholesterol-rich diet.
Zhang Y; Li L; You J; Cao J; Fu X
Drug Des Devel Ther; 2013; 7():233-42. PubMed ID: 23589679
[TBL] [Abstract][Full Text] [Related]
10. Clopidogrel significantly lowers the development of atherosclerosis in ApoE-deficient mice in vivo.
Heim C; Gebhardt J; Ramsperger-Gleixner M; Jacobi J; Weyand M; Ensminger SM
Heart Vessels; 2016 May; 31(5):783-94. PubMed ID: 26062773
[TBL] [Abstract][Full Text] [Related]
11. Irisin protects against endothelial injury and ameliorates atherosclerosis in apolipoprotein E-Null diabetic mice.
Lu J; Xiang G; Liu M; Mei W; Xiang L; Dong J
Atherosclerosis; 2015 Dec; 243(2):438-48. PubMed ID: 26520898
[TBL] [Abstract][Full Text] [Related]
12. The Protective Effect of Bosentan against Atherosclerosis in Apolipoprotein E-Deficient Mice Is Mediated by miRNA-21.
Xu X; Zhao Z; Li G
Biomed Res Int; 2019; 2019():8348430. PubMed ID: 31886257
[TBL] [Abstract][Full Text] [Related]
13. Endothelial Cell-Specific Deletion of P2Y2 Receptor Promotes Plaque Stability in Atherosclerosis-Susceptible ApoE-Null Mice.
Chen X; Qian S; Hoggatt A; Tang H; Hacker TA; Obukhov AG; Herring PB; Seye CI
Arterioscler Thromb Vasc Biol; 2017 Jan; 37(1):75-83. PubMed ID: 27856454
[TBL] [Abstract][Full Text] [Related]
14. TLR4 antagonist reduces early-stage atherosclerosis in diabetic apolipoprotein E-deficient mice.
Lu Z; Zhang X; Li Y; Jin J; Huang Y
J Endocrinol; 2013 Jan; 216(1):61-71. PubMed ID: 23060524
[TBL] [Abstract][Full Text] [Related]
15. Oral flavonoid supplementation attenuates atherosclerosis development in apolipoprotein E-deficient mice.
Hishikawa K; Nakaki T; Fujita T
Arterioscler Thromb Vasc Biol; 2005 Feb; 25(2):442-6. PubMed ID: 15499038
[TBL] [Abstract][Full Text] [Related]
16. Specific dietary polyphenols attenuate atherosclerosis in apolipoprotein E-knockout mice by alleviating inflammation and endothelial dysfunction.
Loke WM; Proudfoot JM; Hodgson JM; McKinley AJ; Hime N; Magat M; Stocker R; Croft KD
Arterioscler Thromb Vasc Biol; 2010 Apr; 30(4):749-57. PubMed ID: 20093625
[TBL] [Abstract][Full Text] [Related]
17. IL-9 aggravates the development of atherosclerosis in ApoE-/- mice.
Zhang W; Tang T; Nie D; Wen S; Jia C; Zhu Z; Xia N; Nie S; Zhou S; Jiao J; Dong W; Lv B; Xu T; Sun B; Lu Y; Li Y; Cheng L; Liao Y; Cheng X
Cardiovasc Res; 2015 Jun; 106(3):453-64. PubMed ID: 25784693
[TBL] [Abstract][Full Text] [Related]
18. Effect of new thiazolidine derivatives LPSF/GQ-02 and LPSF/GQ-16 on atherosclerotic lesions in LDL receptor-deficient mice (LDLR(-/-)).
Soares E Silva AK; de Oliveira Cipriano Torres D; Santos Rocha SW; dos Santos Gomes FO; dos Santos Silva B; Donato MA; Raposo C; Santos AC; de Lima Mdo C; Galdino SL; da Rocha Pitta I; de Souza JR; Peixoto CA
Cardiovasc Pathol; 2013; 22(1):81-90. PubMed ID: 22795892
[TBL] [Abstract][Full Text] [Related]
19. Endothelin-1 overexpression exacerbates atherosclerosis and induces aortic aneurysms in apolipoprotein E knockout mice.
Li MW; Mian MO; Barhoumi T; Rehman A; Mann K; Paradis P; Schiffrin EL
Arterioscler Thromb Vasc Biol; 2013 Oct; 33(10):2306-15. PubMed ID: 23887640
[TBL] [Abstract][Full Text] [Related]
20. Equol Attenuates Atherosclerosis in Apolipoprotein E-Deficient Mice by Inhibiting Endoplasmic Reticulum Stress via Activation of Nrf2 in Endothelial Cells.
Zhang T; Hu Q; Shi L; Qin L; Zhang Q; Mi M
PLoS One; 2016; 11(12):e0167020. PubMed ID: 27907038
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
